摘要
Elimar GOMES 医师
皮肤科医师
Avoiding melanoma understaging: integrating clinical, dermoscopic and pathological data
Objectives: - Identify causes of melanoma understaging related to partial biopsies
- Recognize clinical and dermoscopic features associated with higher tumor risk
- Integrate imaging and pathology to improve staging accuracy and surgical decisions
Introduction: Accurate melanoma staging is essential for prognosis and treatment planning. Partial biopsies and limited clinicopathologic correlation frequently lead to tumor understaging, resulting in inadequate surgical margins and missed indications for sentinel lymph node biopsy.
Materials / method: Representative melanoma cases initially assessed by partial sampling were reviewed. Clinical examination, dermoscopy and advanced imaging were correlated with histopathological parameters including Breslow thickness, ulceration and mitotic index to evaluate their impact on staging accuracy.
Results: Partial biopsies often underestimated tumor thickness and failed to detect high-risk features. Excisional assessment revealed higher Breslow values in several cases, leading to changes in surgical margins and in the indication for sentinel lymph node biopsy.
Conclusion: Melanoma understaging is a major source of therapeutic error. Integrating clinical, dermoscopic, imaging and pathological data improves staging accuracy and supports more appropriate surgical and oncologic management.
披露 - Elimar GOMES
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2026年 5月 21日 - Recorded during IMCAS Americas 2026